NBP 607

Drug Profile

NBP 607

Alternative Names: Cell culture derived trivalent inactivated subunit influenza vaccine - SK Chemicals; NBP607 trivalent; NBP607-V; NBP607-Y; SkyCellFlu; Trivalent inactivated cell culture derived influenza vaccine - SK Chemicals

Latest Information Update: 21 Aug 2015

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator SK Chemicals
  • Class Influenza virus vaccines; Subunit vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Influenza virus infections

Most Recent Events

  • 19 Aug 2015 Launched for Influenza virus infections (In the elderly, Prevention, In volunteers, In adults, In adolescents, In children) in South Korea (IM) - First global launch
  • 15 Mar 2015 Registered for Influenza virus infections (In the elderly, Prevention, In volunteers, In adults) in South Korea - First global approval (IM)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top